ESR1 and complete blood cell count: Women with estrogen receptor-negative (ER-) first primary tumors, particularly those diagnosed at younger ages, may be at increased risk of CBC, and appear more likely to have second tumors that are ER- and high grade, [23, 25–29] potentially reflecting a higher number of BRCA1 mutation carriers in this group [30, 31].